Belyntic
Latest round
- Seed
Last raised
- Apr 2019
Total raised
- $1.5M
Investors
- 1
About Belyntic
Founded in 2018, Belyntic GmbH develops vaccines utilizing its T-Fender platform technology. The company has conducted two deals, with the most recent deal on November 8, 2021, involving a GRANT from the German Federal Ministry for Economic Affairs and Climate Action amounting to EUR 700,000.3 mn.Belyntic focuses on developing T cell-inducing vaccines designed to combat viral and bacterial infectious diseases. Its core offerings include a therapeutic and prophylactic vaccine portfolio that leverages self-adjuvant and self-aggregating synthetic long peptides, aimed at eliciting cellular immune responses. These vaccines particularly focus on protecting vulnerable populations, such as patients undergoing organ transplants, against infections like cytomegalovirus (CMV).Belyntic operates a revenue model based on partnerships with healthcare providers and research institutions for developing its vaccine candidates. This model includes collaborations with pharmaceutical firms and healthcare systems, and revenue is expected to come from licensing agreements and supply contracts related to the T-Fender platform. The company is focused on launching upcoming products designed to enhance its portfolio and is exploring expansion into new markets across Europe and North America by 2023, reflecting the increasing demand for effective immunotherapies.
Who invested in Belyntic
1 investor across 1 round
See all investors in Belyntic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 16, 2019
Amount
$1.5M
Investors
Questions about Belyntic
Who invested in Belyntic?
Belyntic has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Belyntic raised?
Belyntic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Belyntic last raise money?
Belyntic's most recent round on record is a Seed, in Apr 2019.
What does Belyntic do?
Founded in 2018, Belyntic GmbH develops vaccines utilizing its T-Fender platform technology.
Where is Belyntic headquartered?
Belyntic is headquartered in Berlin, Germany.
Which VCs invest in companies like Belyntic?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back chemicals companies at Belyntic's stage. Their profiles are linked below.
VCs backing chemicals startups at Seed
Raising like Belyntic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.